Ariel Investments, LLC — Ariel Global Composite on Akzo Nobel N.V.
Thesis
Ariel bought Akzo Nobel ahead of its combination with Axalta, expecting complementary operations and significant opportunities to remove duplicated costs. Share prices have lagged as investors question deal logic and promised synergies. The manager believes procurement efficiencies, stronger governance and shareholder-aligned incentives can improve profitability. Stabilizing European home renovation and a recovering North American auto-refinish market add cyclical upside that Ariel sees as undervalued.
“the shares have lagged as investors question the strategic rationale and whether the announced cost synergies are achievable.”
Key risks
- The proposed combination remains subject to regulatory review.
- Investors question the strategic rationale and achievability of announced cost synergies.
- A recovery in European home improvement and North American auto-refinish demand may not materialize.